Home » FDA RESTARTS REVIEW OF ENTEREG
FDA RESTARTS REVIEW OF ENTEREG
Pharmaceutical companies Adolor Corp. and GlaxoSmithKline Plc on Wednesday said regulators will resume reviewing the companies' application for a drug to treat intestinal obstructions after new data from a study reaffirmed the drug's effectiveness.
Business Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May